Evolution of the Average Target: Adient plc

Evolution of the Target Price: Adient plc

Changes in Analyst Recommendations: Adient plc

ebb2b2c0b8d0db78162af.NDZQ8vKpseeS8TncFD6zD5rb1x_rQ5wCtIuTInY_vjg.W085uKfB04_LoUmrcVDlbK2Dh02tHMlK_-6hEUNlygpETA-mipr0v-K9cA~00b7c289c61fc19c7cafc13d7ed6589c
05-07 Deutsche Bank Adjusts Adient Price Target to $31 From $30, Maintains Buy Rating MT
04-17 Deutsche Bank Adjusts Adient Price Target to $30 From $33, Maintains Buy Rating MT
02-05 UBS Adjusts Price Target on Adient to $32 From $30, Maintains Buy Rating MT
02-05 Deutsche Bank Upgrades Adient to Buy From Hold, Adjusts Price Target to $33 From $26 MT
01-14 Adient's 'Attractive Valuation' Limits Downside as Shares Trade Near Cyclical Lows, UBS Says MT
01-14 Adient shares climb 6.5% after UBS upgrade, PT raise RE
01-14 UBS Upgrades Adient to Buy From Neutral, Adjusts PT to $30 From $22 MT
11-06 Deutsche Bank Adjusts Adient Price Target to $23 From $27, Maintains Hold Rating MT
11-06 UBS Adjusts Price Target on Adient to $22 From $28, Maintains Neutral Rating MT
06/10/25 UBS Adjusts Price Target on Adient to $28 From $26, Maintains Neutral Rating MT
25/09/25 Adient Shares Rise After Wells Fargo Upgrade MT
25/09/25 Wells Fargo Upgrades Adient to Overweight From Equalweight, Adjusts Price Target to $31 From $24 MT
10/09/25 BofA Securities Adjusts Price Target on Adient to $20 From $17.50, Maintains Underperform Rating MT
21/08/25 Stifel Initiates Adient at Buy With $27 Price Target MT
07/08/25 UBS Adjusts Price Target on Adient to $26 From $25, Maintains Neutral Rating MT
07/08/25 Deutsche Bank Adjusts Adient Price Target to $27 From $23, Maintains Hold Rating MT
14/07/25 UBS Adjusts Price Target on Adient to $25 From $15, Maintains Neutral Rating MT
08/05/25 UBS Raises Price Target on Adient to $15 From $13, Keeps Neutral Rating MT
08/05/25 Deutsche Bank Adjusts Adient Price Target to $18 From $16, Maintains Hold Rating MT
24/04/25 Citigroup Initiates Adient at Neutral With $14 Price Target MT
22/04/25 BofA Adjusts Price Target on Adient to $15 From $18, Maintains Underperform Rating MT
10/04/25 UBS Adjusts Price Target on Adient to $13 From $20, Keeps Neutral Rating MT
04/03/25 Adient, Magna Face Headwinds Amid Weak Production, Industry Volatility, BofA Says MT
04/03/25 BofA Securities Downgrades Adient to Underperform From Neutral MT
28/02/25 Morgan Stanley Adjusts Price Target on Adient to $17 From $19, Maintains Underweight Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+58.67%
+14.36%
- - -
+77.38%
+4%
+8.46%
- +52.71%
+32.17%
- - +53.96%
+45.76%
Average +38.61%
Weighted average by Cap. +35.41%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
20.01USD
Average target price
31.75USD
Spread / Average Target
+58.67%
High Price Target
69.00USD
Spread / Highest target
+244.83%
Low Price Target
22.00USD
Spread / Lowest Target
+9.95%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Deutsche Bank Securities
UBS
Wells Fargo Securities
BofA Securities
Stifel Nicolaus
Citigroup
Morgan Stanley
Barclays
JPMorgan Chase
Benchmark Company
BNP Paribas Exane
Wolfe Research
RBC Capital Markets
Credit Suisse
Benchmark Capital
KeyBanc Capital Markets
J.P. Morgan Chase
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
20.01USD
Average target price
31.75USD
Spread / Average Target
+58.67%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ADNT Stock
  4. Consensus Adient plc